The Zhitong Finance App learned that Curanex Pharmaceuticals (CURX.US), a preclinical biopharmaceutical company that focuses on developing drugs to treat various diseases from plants, submitted an initial public offering (IPO) application to the US Securities and Exchange Commission this Wednesday with the aim of raising up to 10 million US dollars. The company plans to issue 2 million shares at a price of $4 to $6 each, and is expected to have a fully diluted market capitalization of around $210 million.

Zhitongcaijing · 10/17 07:41
The Zhitong Finance App learned that Curanex Pharmaceuticals (CURX.US), a preclinical biopharmaceutical company that focuses on developing drugs to treat various diseases from plants, submitted an initial public offering (IPO) application to the US Securities and Exchange Commission this Wednesday with the aim of raising up to 10 million US dollars. The company plans to issue 2 million shares at a price of $4 to $6 each, and is expected to have a fully diluted market capitalization of around $210 million.